Page last updated: 2024-09-04

1-4-(3-methyltriazeno)benzoic acid and Leukemia L5178

1-4-(3-methyltriazeno)benzoic acid has been researched along with Leukemia L5178 in 1 studies

*Leukemia L5178: An experimental lymphocytic leukemia of mice. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonmassar, E; Christmas, SE; D'Atri, S; Grohmann, U; Moore, M; Romani, L; Tricarico, M1

Other Studies

1 other study(ies) available for 1-4-(3-methyltriazeno)benzoic acid and Leukemia L5178

ArticleYear
Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes.
    International journal of immunopharmacology, 1994, Volume: 16, Issue:7

    Topics: Animals; Antineoplastic Agents; Clone Cells; Cytotoxicity Tests, Immunologic; Female; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Leukemia L5178; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; T-Lymphocytes, Cytotoxic; Triazenes; Tumor Cells, Cultured

1994